MAPT and Alzheimer disease: A large body of literature has demonstrated that the pathogenesis of AD involves multiple mechanisms, including the accumulation of amyloid-beta (Aβ) and tau proteins, activation of neuroinflammatory pathways, disruption of the blood–brain barrier (BBB), and neurovascular dysfunction [5].